Morgan Stanley: CHINA LIFE (02628) Outperforms Peers with Strong New Business Value Growth
Stock News
Oct 31
Morgan Stanley released a research report highlighting that CHINA LIFE (02628) reported its Q3 net profit with the highest earnings growth among peers, up 60.5% for the first nine months of the year. This implies annualized ROE of 88.3% for Q3 and 39.4% for the first nine months. The company's new business value growth accelerated to 41.8% in the first nine months, compared to 20.3% in H1. Morgan Stanley noted that CHINA LIFE's key metrics outperformed most peers, and management remains optimistic about next year's outlook. The bank maintains a target price of HK$25.7 with an "Overweight" rating.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.